H. Mertz et al., Immunohistochemical detection of neuroendocrine markers in tumors of the lungs and gastrointestinal tract, APPL IMMUNO, 6(4), 1998, pp. 175-180
Using immunohistochemistry, we investigated neuroendocrine markers in resec
tion specimens from 94 carcinoids, small cell carcinomas, adenocarcinomas,
and solid carcinomas of the lungs (n = 45) and gut (n = 49). The expression
of chromogranin A, synaptophysin, neuron-specific enolase, protein gene pr
oduct 9.5, and cystatin C in tumors with and without histologic characteris
tics of neuroendocrine differentiation was registered semiquantitatively. U
nexpected immunoreactions in nontumor cells were recorded. Positive stainin
g for chromogranin A and synaptophysin had the highest concordance with a n
euroendocrine morphology. Convincing immunoreactivity for chromogranin A wa
s seen in 97% of the carcinoids, synaptophysin in 100%. Neuron-specific eno
lase, protein gene product 9.5, and cystatin C, on the other hand, had lowe
r concordance with a neuroendocrine morphology and they often showed unexpe
cted immunostaining in many morphologically nonneuroendocrine tumors and in
nontumor cells. We therefore used a positive staining result for chromogra
nin A or synaptophysin as evidence for a neuroendocrine immunophenotype. Ba
sed on this standard, we estimated the sensitivity and specificity for the
other three markers. The overall sensitivity and specificity for neuron-spe
cific enolase was 45% and 67%, respectively, for protein gene product 9.5,
67% and 47%, respectively, and for cystatin C 85% and 47%, respectively. We
conclude that chromogranin A and synaptophysin show high concordance for n
euroendocrine differentiation, whereas the other traditionally used "neuroe
ndocrine" markers (neuron-specific enolase, protein gene product 9.5, and c
ystatin C), are unreliable.